Who is sensitive to the effecs of particulate air pollution on mortality? A case-crossover analysis of effect modifiers

被引:251
作者
Bateson, TF
Schwartz, J
机构
[1] Harvard Univ, Sch Publ Hlth, Environm Epidemiol Program, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA
关键词
D O I
10.1097/01.ede.0000112210.68754.fa
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Populations susceptible to the effects of particulate matter have begun to be characterized, but the independent contributions of specific factors have not been explored. Methods: We used a case-crossover study to examine PM10-associated mortality risk during 1988-1991 among 65,180 elderly residents of Cook County, Illinois, who had a history of hospitalization for heart or lung disease. We assessed how the effect was independently modified by specific diagnoses and personal characteristics. Results: We found a 1.14% (95% confidence interval [CI] = 0.44% to 1.85%) increased risk of death per 10 mug/m(3) increase in ambient PM10 concentration. Persons with heart or lung disease-but no specific diagnosis of myocardial infarction, diabetes, congestive heart failure, chronic obstructive pulmonary disorder, or conduction disorders-were at 0.74% (-0.29% to 1.79%) increased risk. Persons with a history of myocardial infarction had a 2.7-fold higher risk (CI = -2.1 to 7.4). Those with diabetes carried a 2.0-fold higher risk (Cl = -1.5 to 5.5). Risk appeared to decrease with age among elderly men and increase with age among elderly women, but the estimated 3-way interaction was not precise enough to exclude the null. We found no indication that susceptibility varied by group-level socioeconomic measures. Conclusion: Among a frail population, individuals diagnosed with myocardial infarction or diabetes were at greatest risk of death associated with high concentrations of PM,,. These results suggest that their susceptibility may derive from prior vascular damage to the heart.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 46 条
  • [1] [Anonymous], 1998, RES PRIOR AIRB PART
  • [2] Acute effects of particulate air pollution on respiratory admissions - Results from APHEA 2 project
    Atkinson, RW
    Anderson, HR
    Sunyer, J
    Ayres, J
    Baccini, M
    Vonk, JM
    Boumghar, A
    Forastiere, F
    Forsberg, B
    Touloumi, G
    Schwartz, J
    Katsouyanni, K
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (10) : 1860 - 1866
  • [3] Control for seasonal variation and time trend in case crossover studies of acute effects of environmental exposures
    Bateson, TF
    Schwartz, J
    [J]. EPIDEMIOLOGY, 1999, 10 (05) : 539 - 544
  • [4] Selection bias and confounding in case-crossover analyses of environmental time-series data
    Bateson, TF
    Schwartz, J
    [J]. EPIDEMIOLOGY, 2001, 12 (06) : 654 - 661
  • [5] Do respiratory epidemics confound the association between air pollution and daily deaths?
    Braga, ALF
    Zanobetti, A
    Schwartz, J
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (04) : 723 - 728
  • [6] Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults
    Brook, RD
    Brook, JR
    Urch, B
    Vincent, R
    Rajagopalan, S
    Silverman, F
    [J]. CIRCULATION, 2002, 105 (13) : 1534 - 1536
  • [7] Body mass index, diabetes, and C-reactive protein among US adults
    Ford, ES
    [J]. DIABETES CARE, 1999, 22 (12) : 1971 - 1977
  • [8] Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study
    Gerritsen, J
    Dekker, JM
    TenVoorde, BJ
    Bertelsmann, FW
    Kostense, PJ
    Stehouwer, CDA
    Heine, RJ
    Nijpels, G
    Heethaar, RM
    Bouter, LH
    [J]. DIABETOLOGIA, 2000, 43 (05) : 561 - 570
  • [9] Ambient pollution and heart rate variability
    Gold, DR
    Litonjua, A
    Schwartz, J
    Lovett, E
    Larson, A
    Nearing, B
    Allen, G
    Verrier, M
    Cherry, R
    Verrier, R
    [J]. CIRCULATION, 2000, 101 (11) : 1267 - 1273
  • [10] Goldberg M S, 2000, Res Rep Health Eff Inst, P7